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TESTOSTERONE THERAPY I N BOYS WITH DELAYED PUBERTY D e l a y e d p u b e r t y , o f t e n a s s o c i a t e d w i t h s h o r t s t a t u r e i s a common p r o b l e m i n t h e p a e d i a t r i c c l i n i c . T h e s e b o y s ' r e t a r d e d g r o w t h a n d s e x u a l d e v e l o p m e n t c a u s e s c o n s i d e r a b l e d i s t r e s s d u r i n g a d o l e s c e n c e . 8 e c a u s e t e s t o s t e r o n e i s w i d e l y b e l i e v e d t o a c c e l e r a t e b o n e m a t u r a t i o n d i s p r o p o r t i o n a t e l y a n d t t u s r e d u c e f i n a l h e i g h t t h i s t r e a t m e n t i s o f t e n w i t h h e l d .
3 6 b o y s , a g e d 1 2 . 0 -1 7 . 7 ( m e a n 1 4 . 8 ) y r s , w e r e t r e a t e d w i t h t e s t o s t e r o n e o e n a n t h a t e 1 2 5 m g i n t r a m u s c u l a r l y f o r 3 m o n t h s . T h e y w e r e s e e n h a l f y e a r l y a n d h e i g h t s ( H a r p e n d e n s t a d i o m e t e r ) , s k e l e t a l m a t u r a t i o n ( T a n n e r RUS ( T W Z ) ) a n d p u b e r t a l s t a t u s (Tariner a n d W h i t e h o u s e ) w e r e m e a s u r e d .
A t 6 m o n t h s t h e r e w a s a d i s t i n c t a d v a n c e i n p u b e r t d s t a t u s a n d a n i n c r e a s e i n h e i g h t v e l o c i t y f r o m 4.4 t o g . B c m / y e a r . T h e b o y s ' m o r a l e a n d c o n f i d e n c e i n c r e a s e d i m p r e s s i v e l y . l J o s e r i o u s s i d ee f f e c t s w e r e s e e n . l h e e f f e c t s o f t r e a t m e n t o n h e i g h t p r e d i c t i o n a n d h e i g h t s t a n d a r d d e v i a t i o n s c o r e f o r b o n e a g e a r e s h o w n b e l o w : B a s e l i n e . 5 y r 1 y r 1 . 5 -2 y r H t SDS BA -. 9 1 -. l . l B Y * -1 . 0 2 " -1 . 0 9 H t P r e d 1 6 6 . 7 1 6 6 . 5 * 1 6 7 . 3 ' 1 6 7 . 6 N o . ~r e a f m e n t w i t h t e s t o s t e r o n e e f f e c t l v c l y a l l e v i a t~s t h e m a i n p r o b l e m s o f d e l a y e d p u b e r t y a n d o u r d a t a s u g g e s t t h a t a t t h i s d o s a g e i t h a s n o s i g n i f i c a n t e f f e c t o n f i n a l h e i g h t . 
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27 boys ( a g e d 7.6-16yrs) wilh delayed gr0wt.h were s u b d l v~d c d by t e s t l c u l a r s 1 z e irito p r e p u b e r t a l (~4 n 1 l s ) and p u b e r t a l ( b 4 m l s ) . 13 r e c e~v e d 2.5mg/d o x a~i d r o l o n e (Ox) f o r 3 months, and 14 act.ed a s c o n t r o l s . Each group grew a t a v e l o c l t y below t h e 25th c e n t l l c p v e r t h c preceding 0.3-1.4yrs. The c o n t r o l s c o n l l n u e d t.ogrow p o o r l y over (.he next 6 months. Ox promoted all l n c r c a s e I n v e l o c l t y I n p r e p u b e r t a l (4.4 t o 7.5cm/yr, pz0.05) and p u b e r t a l boys ( 4 . 7 t o Dcm/yr, p<0.05) durllig t h e r a p y , n l a l l i t a~n e d over t h e subsequcrit 3 mont.hs only i n t h e p u b e r t a l group (t.0 9.3crn/yr).
The prep u b e r t a l d e c c l e r a t c d a f t e r t reatnicl~t. ( t o 5 . 4 c n 1 /~r ) .
GH secretion ( a r g i r r l n e , GRf a i d d u r~~i g t h e f i r s t 90mlnsof s l c c p ) was a s s c s s c d a t er1t.r~ and 6 months 111 prcpubcrt a1 coot roll;, arid al e n t r y , 3 and 6 niont.hs 111 treat.ed boys. No c h a~i g c i r i peak GH r o sporise o r " a r e a s under curve" (AUC) were s e e n I n t h e p r e p u b e r t a l groups. At 3 a i d 6 mont.tis, t r e a t e d p u b e r t a l boys had s l g n l f l c a r i t l y g r e a t e r AUC and GH peaks d u r l n g s l e e p than t.he p r e p u b e r t a l , assocl a t e d a t 6 mor~ths w1t.h l r i c r e a s e s I n b a s a l i e s t o s t c r o r i c (3.7nn1ol/l a t e n t r y t o 18.2nmol/l, p<0.0 1) arid sonlat oniedin-C ( 140 t o 2 14ri1]/n1l, p<O.05). These changes were n o t see11 I n t h e p r c p u b c r l a l boys.
Ox docs riot a l t e r t h e Gtl s t z~t u s o f p r c p u b c r l a l boys, but enharices growth probably through a d~r e c t a c t l o n on car1 i l...]~,. P e r s~s t c n t growth a c c c l c r ;~t lor1 In t h e pubert a1 boy 1s a s s o c i a t cd w l t h ~n c r e a s e d GH and s o n~a t o n i c d~n l e v e l s .
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CLONlDlNt IRtAIMtNl IN CHILORtN WllH CONSIIIUIIONAL GROWIH UtlAY (CGD) . l e n c h i l d r e n ( 9 males and 1 female; mean age 9.6 y r s ) u e r e t r e a t e d w i t h c l o n l d i - 
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Child Health, London \VCI & Serono Laboratories, \Velwyn Garden City, United 1:ingdom. PHYSIOLOGICAL GI1 SECRETION IN Cf1ILDREPJ WITk1 SHORT STATURE DUE T O LOW BlRTHWEIGI1T/RUSSELL-SILVER SYNDROME. \Ye have studied 24 prepubertal children (7F,17t.1) with short s t a t u r e , mean height SDS -2.8 (range, -5.2 t o -1.7) a s a consequence of intrauterine g r o v t h retardation. hlean a g e a t assessment was 6.3 yrs (ranee. 1.6-9.6). t i e a n birthweight SDS, allowing for gestational a z e , was -2.9 (range, -5.0 t o -2.0). Llean height velocity SDS was -0.9 (ranee, -2.6 t o + 1.0). Mean bone a g e delay was 0.6 "yrs". Patients mere divided into 2 groups; 11(3F,8bl) had dysnlorphic f e a t u r e s of t h e Russell-Silver syndrome (RSS group) and 13 (4F,9h1) did not (non RSS group).
All children had a n overnight serum GH profile from 1900-0800 hrs via a n indwelling intravenous cannula with blood drawn a t 15 minute intervals. A PULSAR computer programme was used for GH pulse analysis. GH pulse frequency, a r e a under t h e GH pulses and sum of t h e GH peaks were calculated. A l l children had a maximum GH peak >20 mU/1 e x c e p t o n e boy who only attained a peak GH of 14mU/I. O n e boy in t h e non RSS group had high frequency "neurpsecretory dysfunction". The most pronounced abnormality in 6 of t h e 11 children with RSS was t h a t only o n e large Gt1 pulse during t h e night was observed with a m e a n value of 37 m u l l (range, 27-65). GH secretion remained d e t e c t a b l e between pulses in 6 of t h e children in t h e non RSS group.
It is probable t h a t more than one endogenous GI3 pulse during t h e night is required for normal growth. Although growth failure in RSS is multif a c t o r a l and end-organ insensitivity is probably important, a b n o r n a l GI1 secretion may be contributory. GROWTH OELAY (CGO) I n 1985, P i n t a r e t a l . r e p o r t e d t h a t treatment u i t h c l o n i d i n e ( C I ) , an 4 2 -ad r e n e r g i c a g o n i s t , accelerates growth i n c h i l d r e n u i t h grouth disorders. I n order t o c o n f i r m o r disprove t h i s observation, we s t u d i e d again the e f f e c t of C1 i n s u b j e c t s u i t h c o n s t i t u t i o n a l grouth delay by c a r r y i n g out a c o n t r o l l e d doubleb l i n d study. 10 p r e p u b e r t a l p a t i e n t s u i t h c h r o n o l o g i c a l age betueen 7 4/12 and I 1 7/12 years and w i t h h e i g h t C 3 r d c e n t i l e and u i t h CGD u c r e selected. Parents consented t o the t r i a l and the p a t i e n t s , a f t e r 6 months' o b e r v a t i o n , were randoml y and b l i n d y a l l o c a t e d t o CI (n.5-group I ) or placebo (n.5-group 2) therapy. C I was administered a t a dose of 0.100 mg.mZ/die.
A f t e r a necks' treatment, a p a t i e n t from group 2 u i t h d r e u from treatment due t o sleepiness. The p a t i e n t s Here measured 6 months before treatment, a t the s t a r t , a f t e r 6 month of treatment and 6 month a f t e r the end of treatment. The h e i g h t v e l o c i t y o f group 1 c h i l d r e n was 4.15, 5.76 and 2.88 cm/ycar r e s p e c t i v e l y before, d u r i n g and a f t e r the 6 months of treatment. w h i l e i n group 2 h e i g h t v e l o c i t y was r e s p e c t i v e l y 4.70. 5.45 and 3.35 cm/year. The d i f f e r e n c e i n h e i g h t v e l o c i t y before and d u r i n g therapy i s s i g n i f i c a n t (p ~0 . 0 5 ) only i n group 1. There i s no d i f f e r e n c e i n h e i d h t v e l o c i t y between the two groups before, d u r i n g and a f t e r treatment. GH peak and area i n t h e a r g i n i n e t e s t and SmC l e v e l s are s i m i l a r i n the tuo groups both before and a f t e r treatment. I t may be concluded t h a t f u r t h e r , wider d o u b l e -b l i n d s t u d i e s are nececsary t o c l a r i f y and q u a n t i f y the e f f e c t of C1 on grouth.
On the b a s i z of r e c e n t evidences, CGO seems t o be a heterogeneous d i s o r d e r and i t has been hypothesized t h a t some of these c h i l d r e n could p r o f i t from d i f f e r e n t therapies.We i n v e s t i g a t e d t h e n a t u r a l outcome of a group o f never t r e a t e d CGO c h i l d r e n e s p e c i a l l y i n regard t o t h e i r F.H..49 c h i l d r e n (35 males and 14 females) w i t h CGO have been f o l l o w e d a t l e a s t y e a r l y s i n c e prepuberty t i l l t h e end of g r o u t h (bone age > 18 y r s i n f.and ) 19 y r r i n n.).At d i a g n o s i s h e i g h t was b e tueen -1 and -3 standard d e v i a t i o n score (SOS)(PO% o f t h e p a t i e n t s < 2.5 HSOS); bone age (BA)at l e a s t <2OS f o r c h r o n o l a g i c a l age (CAIand g r o u t h v e l o c i t y i n t h e low-normal range f o r CA.The most important r e s u l t s can be summarized as f o l l o u s :
-mean F.H. was reached l a t e r than i n normal p o p u l a t i o n (17-23 y r s C A ) ; i t i s a lways i n t h e normal range and w e l l c o r r e l a t e d w i t h t h e g e n e t i c t a r g e t c a l c u l a t e d on t h e b a s i s of p a r e n t a l h e i g h t (=0.68; p < 0 . 0 0 1 ) .~u s t i n 1 case F.H.uasC-2DS from the target.-Height p r e d i c t i o n (Bayley and Pinneau) i s c o r r e l a t e d w i t h F.H.
b o t h i n prepuberty and i n puberty ( p < 0.005);however i t overestimated i n b o t h age groups (31% o f cases i n orepuberty and 26% i n p u b e r t y ) -p u b e r t y s t a r t e d a t 12.4 y r s i n f.and 13 y r s i n n.and ended 3 y r s l a t e r in) both sexes.
I n conclusion, our data confirm t h e f a c t t h a t CGO ( a t l e a s t when p r e p u b e r t a l h e i g h t i s ) -30s) i s a benign c o n d i t i o n r e a c h i n g a l l the p a t i e n t s normal h e i g h t w e l l c o r r e l a t e d w i t h t h e genetic t a r g e t .
